Matches in Wikidata for { <http://www.wikidata.org/entity/Q89482814> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q89482814 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q89482814 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89482814 description "scientific article published on 30 January 2020" @default.
- Q89482814 description "wetenschappelijk artikel" @default.
- Q89482814 description "наукова стаття, опублікована 30 січня 2020" @default.
- Q89482814 name "Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial" @default.
- Q89482814 name "Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial" @default.
- Q89482814 type Item @default.
- Q89482814 label "Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial" @default.
- Q89482814 label "Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial" @default.
- Q89482814 prefLabel "Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial" @default.
- Q89482814 prefLabel "Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial" @default.
- Q89482814 P1433 Q89482814-4CB9C8C4-263C-4116-842F-79BA92AE3349 @default.
- Q89482814 P1476 Q89482814-1E503C54-6E3A-4B74-9275-DC775E196B3E @default.
- Q89482814 P2093 Q89482814-25A77D21-574E-4B59-A701-BE1ED699E0BE @default.
- Q89482814 P2093 Q89482814-83EEA136-079E-4180-A8BE-D1092F3AB380 @default.
- Q89482814 P2093 Q89482814-8FBAB0DB-6CC3-44F1-8E7B-175091627976 @default.
- Q89482814 P2093 Q89482814-A05144F9-2377-4717-B1C6-632B5F3CCFF4 @default.
- Q89482814 P2093 Q89482814-C5313E94-EE60-4D89-B56D-612BCEF2B7FF @default.
- Q89482814 P2093 Q89482814-EAF758ED-B1F9-48FD-827A-DACA2F846887 @default.
- Q89482814 P31 Q89482814-7D1EC19D-D785-470B-BF35-9C7347FB44D4 @default.
- Q89482814 P356 Q89482814-12020F4F-1B83-4947-A8B0-937DC135800E @default.
- Q89482814 P577 Q89482814-26E021C2-1CAD-46FC-A8F3-21D80812600D @default.
- Q89482814 P698 Q89482814-804276D0-254A-4095-B4D4-EE43606FC66C @default.
- Q89482814 P921 Q89482814-45077550-B1A3-4E74-80D6-EA39799C7569 @default.
- Q89482814 P921 Q89482814-679B3A4B-2E94-43B2-B891-0AAE014DD3A0 @default.
- Q89482814 P356 J.JAAD.2020.01.056 @default.
- Q89482814 P698 32007513 @default.
- Q89482814 P1433 Q15757046 @default.
- Q89482814 P1476 "Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial" @default.
- Q89482814 P2093 "David M Pariser" @default.
- Q89482814 P2093 "Elaine Chien" @default.
- Q89482814 P2093 "Gil Yosipovitch" @default.
- Q89482814 P2093 "Jerry Bagel" @default.
- Q89482814 P2093 "Mark Lebwohl" @default.
- Q89482814 P2093 "Mary C Spellman" @default.
- Q89482814 P31 Q13442814 @default.
- Q89482814 P356 "10.1016/J.JAAD.2020.01.056" @default.
- Q89482814 P577 "2020-01-30T00:00:00Z" @default.
- Q89482814 P698 "32007513" @default.
- Q89482814 P921 Q269829 @default.
- Q89482814 P921 Q42824440 @default.